Invesco Pharmaceuticals ETF

PJP · ETF

$125.03−$2.28 (−1.79%)TodayMarket closed · Oct 23, 8:00 PM ET

Prev close $127.31

Latest news

NewsSep 8, 12:50 PM ETVandana Singh
What's Going On With Amgen Stock Tuesday?
NewsJul 24, 6:25 AM ETStjepan Kalinic
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
NewsApr 6, 10:57 AM ETVandana Singh
Amgen Posts 77% Response In Thyroid Eye Disease Study
NewsFeb 17, 10:15 AM ETVandana Singh
Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial
NewsJan 16, 2:30 AM ETRishabh Mishra
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
NewsNov 12, 6:22 AM ETRishabh Mishra
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
NewsSep 29, 3:20 AM ETRishabh Mishra
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
NewsJul 16, 3:22 AM ETRishabh Mishra
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
NewsJul 11, 7:57 AM ETRishabh Mishra
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
NewsMay 19, 3:50 AM ETRishabh Mishra
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
NewsMay 11, 10:19 PM ETAnanya Gairola
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
NewsApr 23, 7:43 AM ETNamrata Sen
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
NewsAug 19, 12:08 PM ETMichael Juliano
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
NewsJul 18, 3:59 PM ETMichael Juliano
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

What's Going On With Amgen Stock Tuesday?

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

Amgen Posts 77% Response In Thyroid Eye Disease Study

Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial

Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion

Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'

Trump Administration Considers Lowering US Drug Prices To International Levels: Report

FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch

COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch